https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/en-ukCopyright (C) 2026 newslocker.comFri, 04 Sep 2026 21:32:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/evidence-insufficient-to-support-routine-lumbar-support-use-for-chronic-low-back-pain/Fri, 04 Sep 2026 21:32:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/evidence-insufficient-to-support-routine-lumbar-support-use-for-chronic-low-back-pain/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/people-using-illicitly-sourced-fentanyl-face-worse-outcomes-than-medically-sourced-users/Fri, 04 Sep 2026 21:24:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/people-using-illicitly-sourced-fentanyl-face-worse-outcomes-than-medically-sourced-users/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/recommendations-updated-for-adult-stroke-rehabilitation-recovery/Fri, 04 Sep 2026 16:22:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/recommendations-updated-for-adult-stroke-rehabilitation-recovery/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/noacs-linked-to-slower-cognitive-decline-in-patients-with-a-fib-alzheimer-disease/Fri, 04 Sep 2026 16:18:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/noacs-linked-to-slower-cognitive-decline-in-patients-with-a-fib-alzheimer-disease/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/adverse-pathological-features-do-not-predict-benefit-of-hormone-therapy-in-prostate-cancer/Fri, 04 Sep 2026 16:12:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/adverse-pathological-features-do-not-predict-benefit-of-hormone-therapy-in-prostate-cancer/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/preoperative-iv-iron-beneficial-for-patients-with-anemia-undergoing-cardiac-surgery/Fri, 04 Sep 2026 16:07:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/preoperative-iv-iron-beneficial-for-patients-with-anemia-undergoing-cardiac-surgery/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/dementia-stroke-risk-elevated-for-those-with-severe-mental-illness/Fri, 04 Sep 2026 16:03:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/dementia-stroke-risk-elevated-for-those-with-severe-mental-illness/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/alcohol-attributable-cancer-mortality-has-increased-significantly-in-the-us/Thu, 03 Sep 2026 23:00:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/alcohol-attributable-cancer-mortality-has-increased-significantly-in-the-us/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/fda-approves-first-in-class-drug-for-polycythemia-vera/Thu, 03 Sep 2026 22:56:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/fda-approves-first-in-class-drug-for-polycythemia-vera/ Mimrylo mimics hepcidin, a...]]>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/fda-approves-mimrylo-a-first-in-class-drug-for-polycythemia-vera/Thu, 03 Sep 2026 22:09:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/fda-approves-mimrylo-a-first-in-class-drug-for-polycythemia-vera/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/maintaining-physical-activity-tied-to-better-quality-of-life-with-multiple-sclerosis/Thu, 03 Sep 2026 17:35:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/maintaining-physical-activity-tied-to-better-quality-of-life-with-multiple-sclerosis/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/azacitidine-venetoclax-tied-to-improved-event-free-survival-in-adults-with-aml/Thu, 03 Sep 2026 17:35:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/azacitidine-venetoclax-tied-to-improved-event-free-survival-in-adults-with-aml/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/very-low-carb-diet-shows-greater-cardiometabolic-benefits-than-other-diets/Thu, 03 Sep 2026 17:32:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/very-low-carb-diet-shows-greater-cardiometabolic-benefits-than-other-diets/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/about-1-in-20-hospitalized-us-adults-with-firearm-injuries-develop-bacterial-infections/Thu, 03 Sep 2026 17:28:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/about-1-in-20-hospitalized-us-adults-with-firearm-injuries-develop-bacterial-infections/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/intensive-bp-lowering-reduces-recurrent-stroke-after-intracerebral-hemorrhage/Thu, 03 Sep 2026 17:23:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/intensive-bp-lowering-reduces-recurrent-stroke-after-intracerebral-hemorrhage/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/focal-therapy-use-remains-uncommon-in-nonmetastatic-prostate-cancer/Thu, 03 Sep 2026 16:57:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/focal-therapy-use-remains-uncommon-in-nonmetastatic-prostate-cancer/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/causes-outcomes-of-traumatic-brain-injury-identified-worldwide/Thu, 03 Sep 2026 16:50:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/causes-outcomes-of-traumatic-brain-injury-identified-worldwide/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/fda-clears-blood-test-for-alzheimer-disease/Thu, 03 Sep 2026 16:44:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/fda-clears-blood-test-for-alzheimer-disease/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/time-restricted-eating-may-help-patients-with-type-1-diabetes/Wed, 02 Sep 2026 22:26:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/time-restricted-eating-may-help-patients-with-type-1-diabetes/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/residential-context-has-larger-impact-on-ovarian-cancer-survival-in-black-women/Wed, 02 Sep 2026 22:23:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/residential-context-has-larger-impact-on-ovarian-cancer-survival-in-black-women/